JinMeds Nanobathing Products Receive Multiple Patent Certifications and Sign Directed Procurement Agreement with Shanghai Zhongjin HongKang Medical Technology
| ZJYL Stock | 0.95 0.11 10.38% |
About 63% of JIN MEDICAL's investor base is looking to short. The analysis of overall sentiment of trading JIN MEDICAL INTERNATIONAL stock suggests that many investors are alarmed at this time. JIN MEDICAL's investing sentiment shows overall attitude of investors towards JIN MEDICAL INTERNATIONAL.
JIN |
CHANGZHOU, China, Aug. 3, 2023 PRNewswire Jin Medical International Ltd. which is the worlds leading provider of rehabilitation equipment. Currently,
Read at benzinga.com
 |
JIN MEDICAL Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards JIN MEDICAL can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
JIN MEDICAL Fundamental Analysis
We analyze JIN MEDICAL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of JIN MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of JIN MEDICAL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
JIN MEDICAL is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
JIN MEDICAL INTERNATIONAL Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with JIN MEDICAL stock to make a market-neutral strategy. Peer analysis of JIN MEDICAL could also be used in its relative valuation, which is a method of valuing JIN MEDICAL by comparing valuation metrics with similar companies.
Peers
JIN MEDICAL Related Equities
| ACON | Aclarion | 5.88 | ||||
| NUTX | Nutex Health | 3.98 | ||||
| BEAT | Heartbeam | 1.43 | ||||
| MGRX | Mangoceuticals, Common | 1.13 | ||||
| EUDA | EUDA Health | 4.64 | ||||
| HCTI | Healthcare Triangle | 18.35 |
Check out JIN MEDICAL Hype Analysis, JIN MEDICAL Correlation and JIN MEDICAL Performance. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.12) | Earnings Share 0.02 | Revenue Per Share 0.129 | Quarterly Revenue Growth 0.03 | Return On Assets 0.0403 |
The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.